Provided by Tiger Trade Technology Pte. Ltd.

Dermata Therapeutics Inc

1.21
+0.02001.68%
Post-market: 1.470.2601+21.50%19:03 EDT
Volume:2.25M
Turnover:3.04M
Market Cap:3.43M
PE:-0.10
High:1.25
Open:1.19
Low:1.17
Close:1.19
52wk High:23.70
52wk Low:1.11
Shares:2.84M
Float Shares:1.98M
Volume Ratio:30.94
T/O Rate:113.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.1295
EPS(LYR):-80.3223
ROE:-203.36%
ROA:-96.45%
PB:0.87
PE(LYR):-0.02

Loading ...

Dermata Therapeutics SVP Regulatory Affairs Maria E Bedoya-Toro Munera acquires USD 1,270 in common shares

Reuters
·
Mar 18

Dermata Therapeutics Inc expected to post a loss of $1.54 a share - Earnings Preview

Reuters
·
Mar 14

Dermata Therapeutics appoints Kyra Peckaitis as VP of Marketing

Reuters
·
Mar 10

Dermata Therapeutics Unveils Tome Skincare Line

Reuters
·
Mar 05

Dermata Therapeutics Director Mary Fisher Resigns Effective March 31, 2026

Reuters
·
Feb 26

Dermata Therapeutics files to sell 1.48M shares of common stock for holders

TIPRANKS
·
Jan 23

Dermata Therapeutics Granted Australian Patent for Spongilla-Based Acne Treatment

Reuters
·
Jan 20

Dermata Therapeutics Announces $12.4 Million Private Placement With Warrants and Share Issuance

Reuters
·
Dec 30, 2025

Top Midday Decliners

MT Newswires Live
·
Dec 27, 2025

Why Is Dermata Therapeutics Stock Surging Wednesday?

Benzinga_recent_news
·
Dec 25, 2025

Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating

TIPRANKS
·
Nov 26, 2025

BRIEF-Dermata Therapeutics Inc Files For Mixed Shelf Of Up To $100 Million

Reuters
·
Nov 25, 2025

Dermata Therapeutics files $100M mixed securities shelf

TIPRANKS
·
Nov 25, 2025

BRIEF-Dermata Therapeutics terminates license agreement with Villani dated March 31, 2017, says in SEC Filing

Reuters
·
Nov 18, 2025

Dermata Therapeutics Inc - Termination Linked to Strategic Shift to Otc Skin Care - SEC Filing

THOMSON REUTERS
·
Nov 18, 2025

Dermata Therapeutics : Villani Will Not Be Entitled to Receive Any Further Milestones or Other Payments Due After Termination Date

THOMSON REUTERS
·
Nov 18, 2025

Dermata Therapeutics Inc - on Nov 17, Terminates License Agreement With Villani Dated March 31, 2017 - SEC Filing

THOMSON REUTERS
·
Nov 18, 2025

BRIEF-Dermata Therapeutics Announces Strategic Pivot To OTC Skin Care - SEC Filing

Reuters
·
Nov 15, 2025

Dermata Therapeutics Q3 net loss narrows as R&D expenses fall

Reuters
·
Nov 15, 2025

Dermata Therapeutics Inc - to Launch First Otc Acne Kit Mid-2026 - SEC Filing

THOMSON REUTERS
·
Nov 15, 2025